Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Irving

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Journal of Medicinal Chemistry|January 14, 2000
Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanismK Biggadike, R M Angell, C M Burgess, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
The discovery of GSK221149A: a potent and selective oxytocin antagonistJohn Liddle, Michael J Allen, Alan D Borthwick, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifsNigel S Watson, Carl Adams, David Belton, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifsRobert J Young, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifsRobert J Young, Carl Adams, Mike Blows, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifsSavvas Kleanthous, Alan D Borthwick, David Brown, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Journal of Medicinal Chemistry|January 14, 2000
Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanismK Biggadike, R M Angell, C M Burgess, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
The discovery of GSK221149A: a potent and selective oxytocin antagonistJohn Liddle, Michael J Allen, Alan D Borthwick, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifsNigel S Watson, Carl Adams, David Belton, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifsRobert J Young, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifsRobert J Young, Carl Adams, Mike Blows, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifsSavvas Kleanthous, Alan D Borthwick, David Brown, et al.
Pageof 13